However, while the death of dopaminergic neurons in the substantia nigra of the brain is the most prominent disease presentation in patients with PINK1 mutations, recent reports have implicated PINK1 gene dysfunction or dysregulation as a potential risk factor for the metabolic disorder T2DM [11,12]. This evidence concerns the gene PINK1 and metabolic disease.